Navigation Links
Vascular Study Group of New England Selects Clinical Data Pathways, Powered by M2S, as Quality Improvement Registry Provider
Date:10/20/2009

M2S, Inc. and the Vascular Study Group of New England (VSGNE) have partnered to advance the VSGNE quality improvement registry. Clinical Data Pathways, powered by M2S, is a secure, web-based clinical data management solution that offers physicians, hospitals, medical centers and clinical researchers the power to assess outcomes, enhance clinical quality and improve practice standards while providing the customer with complete control of their data.

West Lebanon, NH (PRWEB) October 20, 2009 -- M2S, Inc. and the Vascular Study Group of New England (VSGNE) have partnered to advance the VSGNE quality improvement registry. Clinical Data Pathways, powered by M2S, is a secure, web-based clinical data management solution that offers physicians, hospitals, medical centers and clinical researchers the power to assess outcomes, enhance clinical quality and improve practice standards while providing the customer with complete control of their data.

The VSGNE quality improvement registry, formed in 2002, has prospectively collected data on more than 12,000 patients undergoing carotid endarterectomy, carotid stenting, lower extremity arterial bypass and open and endovascular repair of abdominal aortic aneurysms. There are currently twelve hospital members of the VSGNE from Massachusetts, Maine, New Hampshire and Vermont. By studying their outcomes, the group has been able to identify best processes of care and better patient selection algorithms to improve patient outcomes.

It is the vision of both the VSGNE and M2S that the vascular quality improvement registry model will be replicated in other regions of the United States, facilitating widespread benchmarking and quality initiatives to improve patient outcomes. The collection and exchange of anonymous aggregate data across multiple participants in the registry fosters continuous improvement in the quality, safety, effectiveness and cost of caring for patients.

"M2S is excited to be part of the VSGNE's mission to improve quality and enhance clinical outcomes within the region and across the country. As a provider of leading medical imaging tools for vascular surgeons, our company embraces technological advances and are certain that our data management solution will meet the growing needs of healthcare organizations," M2S CEO Wes Chapman commented.

"We selected M2S as our vendor because of its experience with vascular image management registries, its status as a six sigma company with established protocols for data integrity and its powerful database platform using Oracle Clinical," Jack Cronenwett, M.D. from Dartmouth-Hitchcock Medical Center and Principal Investigator of the VSGNE, stated.


About M2S, Inc.
M2S offers medical data and image management services across the healthcare continuum based on best-in-class technology and continuous quality improvement processes, including clinical data management solutions, clinical trials and advanced radiographic image analysis. With over 10 years of experience, M2S has created Clinical Data Pathways to give health care providers greater ownership and control of patient data, provide real-time access to risk-adjusted benchmarked reports and facilitate local, regional and national data collaboration. All M2S services focus on increasing operational efficiency, reducing total cost and maintaining or enhancing clinical quality. For more information, visit www.m2s.com.

###

Read the full story at http://www.prweb.com/releases/medical/imaging/prweb3074594.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Study questions need for routine intervention in patients with renovascular disease
2. Good Samaritan Hospital-Dayton Rated #1 in Ohio for Vascular Surgery; #1 in Dayton for Joint Replacement
3. Cardiovascular Systems Announces Plans for Second Manufacturing Facility - New Facility Expands CSI's Capacity to Produce Peripheral Arterial Disease Systems
4. 8 Ounces a Day of POM Wonderful 100% Pomegranate Juice May Slow Progression of Carotid Intima-Media Thickness (CIMT) in Patients with Elevated Cardiovascular Disease Risk Factors, Study Finds
5. BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease
6. MAQUET Cardiovascular Receives FDA Clearance for MEGA(TM), the Worlds First 8Fr. 50cc Intra-Aortic Balloon Catheter
7. Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting
8. Concentric Medical Launches Full Family of DAC(TM) Neurovascular Catheters
9. Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009
10. Health Leaders Issue Recommendations to Improve Management of a Common, Costly and Misunderstood Cardiovascular Disease: Atrial Fibrillation
11. Dr. Eliscer Guzman, with The Mount Sinai Medical Center, Join Forces to Celebrate the Community Diabetes and Cardiovascular Care Programs Graduation Ceremony on September 16th
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vascular Study Group of New England Selects Clinical Data Pathways, Powered by M2S, as Quality Improvement Registry Provider
(Date:2/10/2016)... Angeles, CA (PRWEB) , ... February 10, 2016 ... ... Programming (NLP) practitioner, is known locally for a series of therapeutic sessions to ... in-the-moment in their characters and in their lives. The series, known as “Mindfulness ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... unveiling its revolutionary new 2.0 version at the International Roofing Expo in Orlando, ... power of the world's most advanced weather technology in the hands of consumers, ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... master charity program created to assist the local community. Pledging to select a ... and nonprofit organizations in the area. Their goal is to bring community awareness ...
(Date:2/10/2016)... ... ... Ongoing news of the ravages of traumatic brain injury (TBI) among former ... takes a closer look at cases of TBI being managed by their members. The ... the aging population, and identifies the challenges associated with their care. , During the ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed a ... network of laboratory service centers across the country. Launched in April of 2015, Apifiny ... detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... cell disease and heart failure, today announced the pricing ... a price to the public of $0.275 per unit. ... common stock and one warrant to purchase one share ... of $0.42 per share. The warrants are exercisable six ...
(Date:2/10/2016)... Feb. 10, 2016  Silicon Biosystems Menarini Inc., ... that help uncover the biological complexities of disease ... a developer of innovative technologies for genomics research, ... aimed at enabling translational researchers to obtain high-quality ... hundred tumor and normal cells in an optimized ...
(Date:2/10/2016)... Feb. 9, 2016 CTI BioPharma Corp. ... an update regarding the clinical studies being conducted ... for pacritinib. Following the issuance of the Company,s ... clinical hold issued by the U.S. Food and ... Company received an oral communication from the FDA ...
Breaking Medicine Technology: